More Americans Are Making Mental Health a Priority in 2026—And New Treatments Are on the Horizon

More Americans than ever are prioritizing their mental health as we enter 2026, with 38% planning mental health-related New Year's resolutions—a 5% increase from last year. This growing focus on mental wellness comes at a pivotal time, as several groundbreaking anxiety treatments are moving through final clinical trials and could reach patients by the end of the year.

Why Are More People Focusing on Mental Health This Year?

The shift toward mental health prioritization is particularly pronounced among younger adults, with 58% of those ages 18-34 planning mental health resolutions compared to just 32% of 45-64 year-olds and 11% of those 65 and over. Mental health now ranks as the third most common resolution category, following physical fitness at 44% and financial goals at 42%.

"It is encouraging to see more individuals planning to prioritize their mental health in 2026, particularly younger adults," said American Psychiatric Association (APA) President Theresa Miskimen Rivera, M.D. "The strategies people are embracing—such as regular physical activity, mindfulness practices, adequate sleep, time in nature and engaging in therapy—reflect a growing recognition that mental health is deeply connected to daily habits."

What New Anxiety Treatments Are Coming in 2026?

After more than a decade without major breakthroughs in anxiety medication, three promising treatments are now in advanced clinical trials, each using completely different approaches than traditional selective serotonin reuptake inhibitors (SSRIs) and benzodiazepines.

• MM120 (Psychedelic-Based): MindMed's investigational treatment uses a small, precisely controlled dose of a psychedelic compound (a form of LSD) that dissolves on the tongue for generalized anxiety disorder (GAD). In Phase 2 studies, participants reported improvement in anxiety symptoms after a single dose, with potential benefits lasting up to 12 weeks.
• GlyphAllo (Hormone-Based): Seaport Therapeutics is developing this oral treatment for major depressive disorder with anxiety symptoms. It's designed to improve absorption of allopregnanolone, a naturally occurring hormone-like substance that helps the brain manage stress and regulate mood.
• Fasedienol (Nasal Spray): Vistagen's nasal spray uses a pherine compound that acts through nerves in the nasal passages, sending signals directly to brain regions involved in mood and social comfort. Because it works locally rather than circulating throughout the body, researchers are studying whether it can provide fast-acting, on-demand relief for social anxiety situations.

These investigational medications represent a significant shift toward new biological targets and precision delivery systems that go beyond traditional antidepressant mechanisms. If upcoming trial results are positive, 2026 may mark a meaningful turning point toward faster-acting, more personalized anxiety treatments.

What's Driving America's Mental Health Concerns?

Despite the increased focus on mental wellness, anxiety remains widespread among Americans heading into 2026. The top sources of anxiety include personal finances at 59%, uncertainty about the next year at 53%, and current events at 49%. Physical and mental health concerns follow closely behind these financial and uncertainty-related worries.

Looking back on 2025, 63% of Americans rated their mental health as excellent or good, while 28% said it was fair and 8% said it was poor. "A new year can bring change, possibility, and uncertainty," said APA CEO and Medical Director Marketa M. Wills, M.D., M.B.A. "Feelings of anxiousness underscore the importance of paying attention to how we're doing and taking practical steps, large or small, to support our mental health."

The convergence of increased mental health awareness and breakthrough treatment options suggests 2026 could be a transformative year for anxiety and depression care. As more Americans commit to prioritizing their mental wellness through resolutions and lifestyle changes, they may soon have access to innovative treatments that work faster and more precisely than ever before.